Introducing the GluCath®
Intravascular Continuous Glucose Monitoring System
Numerous clinical studies have demonstrated that glycemic control of intensive care patients may dramatically improve clinical outcomes. Blood glucose is often referred to as an evolving “vital sign” in the management of the critically ill. more >
The GluCath intravascular continuous monitor* is being designed to meet the challenges of safely and effectively implementing a tight glycemic control program in the critical care environment. more >
GluMetrics, Inc. is the emerging medical device company developing this solution, combining a novel fluorescent chemistry with a patented, miniaturized fiber-optic platform. more >
*CAUTION–Investigational Device. Limited by United States law to investigational use.